DONNINI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 10.084
EU - Europa 7.958
AS - Asia 3.879
SA - Sud America 622
AF - Africa 101
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.660
Nazione #
US - Stati Uniti d'America 9.984
GB - Regno Unito 2.049
RU - Federazione Russa 1.605
CN - Cina 1.430
SG - Singapore 1.197
IE - Irlanda 1.128
IT - Italia 739
SE - Svezia 623
UA - Ucraina 580
BR - Brasile 555
DE - Germania 414
FR - Francia 372
HK - Hong Kong 324
VN - Vietnam 262
KR - Corea 227
FI - Finlandia 216
IN - India 205
TR - Turchia 62
ES - Italia 53
CA - Canada 50
BE - Belgio 34
BD - Bangladesh 33
MX - Messico 33
CI - Costa d'Avorio 31
NL - Olanda 29
PL - Polonia 29
AR - Argentina 26
ZA - Sudafrica 26
IQ - Iraq 21
AT - Austria 19
JP - Giappone 17
MA - Marocco 14
ID - Indonesia 12
EC - Ecuador 11
IL - Israele 10
LT - Lituania 10
AU - Australia 9
PK - Pakistan 9
CO - Colombia 8
NP - Nepal 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
TN - Tunisia 7
VE - Venezuela 7
GR - Grecia 6
PT - Portogallo 6
RO - Romania 6
BY - Bielorussia 5
IR - Iran 5
KE - Kenya 5
BO - Bolivia 4
CL - Cile 4
DK - Danimarca 4
EU - Europa 4
HN - Honduras 4
JO - Giordania 4
LU - Lussemburgo 4
SA - Arabia Saudita 4
TW - Taiwan 4
AZ - Azerbaigian 3
KG - Kirghizistan 3
KH - Cambogia 3
LK - Sri Lanka 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
BH - Bahrain 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
PA - Panama 2
PH - Filippine 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MZ - Mozambico 1
NI - Nicaragua 1
SN - Senegal 1
SO - Somalia 1
Totale 22.658
Città #
Southend 1.867
Dallas 1.269
Dublin 1.112
Fairfield 1.072
Ashburn 818
Singapore 757
Chandler 639
Houston 592
Woodbridge 496
Jacksonville 486
Santa Clara 440
Seattle 416
Wilmington 416
Moscow 412
Beijing 364
Cambridge 353
Hong Kong 317
Ann Arbor 261
Hefei 228
Seoul 227
Princeton 226
Siena 225
Dong Ket 154
Menlo Park 147
Los Angeles 141
Nanjing 135
Pune 100
Munich 89
Helsinki 86
Boardman 84
Florence 82
New York 82
The Dalles 82
San Diego 78
Milan 74
Fremont 66
San Mateo 66
Columbus 53
Bengaluru 52
Buffalo 50
Council Bluffs 50
São Paulo 42
Tianjin 40
Redondo Beach 39
Nanchang 37
Ho Chi Minh City 36
London 35
Shenyang 35
Brussels 34
Kunming 34
Izmir 33
Turku 33
Abidjan 31
Dearborn 31
Rome 31
Hebei 30
Málaga 30
Shanghai 30
Warsaw 27
Brooklyn 25
Hanoi 24
Nuremberg 24
San Francisco 23
Chicago 21
Lancaster 21
Jinan 20
Prato 20
Changsha 19
Toronto 19
Zhengzhou 19
Atlanta 18
Phoenix 18
Chennai 17
Denver 17
Frankfurt am Main 17
Hangzhou 17
Norwalk 17
San Jose 17
Düsseldorf 16
Tokyo 16
Amsterdam 15
Guangzhou 15
Mexico City 15
Montreal 15
Jiaxing 14
Johannesburg 14
Poplar 14
Brasília 13
Falls Church 13
Orem 13
Redwood City 13
Vienna 13
Belo Horizonte 12
Rio de Janeiro 12
Stockholm 12
Boston 10
Ningbo 10
Taizhou 9
Bologna 8
Charlotte 8
Totale 15.925
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 397
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 385
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 312
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 293
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 288
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 284
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 271
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 270
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 266
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 261
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 248
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 243
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 242
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 242
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 241
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 235
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 232
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 232
Divergent effects of quercetin conjugates on angiogenesis 230
Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends 230
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 229
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 226
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 224
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 221
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 218
Development of phenol-enriched olive oil with phenolic compounds extracted from wastewater produced by physical refining 217
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction 217
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 215
Studying vascular angiogenesis and senescence in zebrafish embryos 214
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 214
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 212
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 211
Biological characterization of nanocomposite hydrogels 208
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion 208
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 207
Activity of "NO-donor" or "NO-mediated" drugs 205
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 202
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 198
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling 194
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 193
Assessing vascular senescence in zebrafish 192
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 191
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 191
Differential contribution of bradykinin receptors in angiogenesis 190
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 188
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 188
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 187
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 187
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 186
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 185
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 181
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 179
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 178
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 177
Targeting Integrins in Cancer 177
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 176
Molecular mechanisms of resistance to anti-angiogenic drugs 176
Angiogenesis 175
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 174
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 173
Role of nitric oxide in the modulation of angiogenesis 171
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 171
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 169
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 166
Expression and localization of placenta growth factor and PlGF receptors in human meningiomas 166
Nitric oxide in tumor angiogenesis 166
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 166
Nitric oxide and angiogenesis 164
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 162
Effect of Hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1 161
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 160
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 159
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 158
Oxidative Stress and Membrane Transport Systems 158
Repurposing of drugs for triple negative breast cancer: an overview 157
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 156
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 156
Use of Nutraceuticals in Angiogenesis-Dependent Disorders 156
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 154
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 153
Constitutive and inducible nitric oxide synthase: role in angiogenesis 153
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 153
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 153
ETB receptors promote proliferation and migration of endothelial cells 152
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 152
Hydrogen peroxide mediates endothelium-dependent dilation of coronary arterioles in obese rats on low carbohydrate diet 151
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 150
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 150
Mitochondrial aldehyde dehydrogenase-2 activation prevents β amyloids induced endothelial cell dysfunction and restores angiogenesis. 149
Role of nitric oxide in tumor angiogenesis 149
alpha(1D)-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed 149
Endostatin: a promising drug for antiangiogenic therapy 148
Molecular mechanisms of VEGF-induced angiogenesis 148
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium 148
Nitric oxide and PGE-2 cross-talk in EGFR-driven epithelial tumor cells 147
Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1 146
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 145
Role of prostaglandin E2 in EGFR mediated DU145 prostate cancer growth and epithelial mesenchymal transition 145
Inflammation and tumor progression: role of prostaglandin E2 pathway 144
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium 143
Totale 19.490
Categoria #
all - tutte 71.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.756 0 0 0 0 0 305 102 389 291 234 148 287
2021/20221.631 86 230 88 197 76 80 70 64 57 156 168 359
2022/20232.289 136 194 301 330 217 477 46 173 235 54 67 59
2023/20241.671 63 38 105 144 45 511 582 41 4 19 14 105
2024/20253.328 67 177 321 251 362 192 79 181 272 129 412 885
2025/20265.627 685 1.110 993 929 1.701 209 0 0 0 0 0 0
Totale 22.924